ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis

K. Yoon, K. Lee, S. Hong, J-.H. Cho, J-.M. Lee, N-.J. Yi, K. Suh.

Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

Meeting: 2018 American Transplant Congress

Abstract number: B270

Keywords: Recurrence, Survival

Session Information

Date: Sunday, June 3, 2018

Session Name: Poster Session B: Liver: Hepatocellular Carcinoma and Other Malignancies

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.
  • Comparison of Long-Term Survival Outcome Between Primary Liver Transplantation and Hepatic Resection with Consequent Salvage Transplantation for Hepatocellular Carcinoma within Milan Criteria – A Single-Center Experience.

Introduction: Liver transplantation(LT) has better outcomes even in patient with child A than LR because LT can overcome the tumor and background liver factors. We hypothesis that the according to the background liver and tumor biology, treatment option would be different.

Method: We reviewed patient data who received LR or LT in Seoul National university hospital. The patient was divided into two groups according to the platelet count which reflect the cirrhosis. We performed risk factor analysis using only preoperative risk factors. Platelet was used as a background liver factor(>100K=no or mild cirrhosis, 100K=moderate to severe cirrhosis) and AFP and tumor size and number is used as tumor characteristics.

Result: Total 663 and 210 patient was included in LR and LT group. We compared overall survival(OS) and recurrence free survival(RFS) between LR and LT group according to platelet count. Three factors were used which was significant in multivariate analysis, AFP >100, the number of tumor >1, the size of tumor > 5cm as a tumor factor. If no risk factors in platelet>100K group. RFS and OS were not different in both group. If one risk factors, OS was similar but RFS is higher in LT group. If 2 risk factors, OS is higher in LT group. In platelet <100K group, if no risk, OS was similar in both group. But if 1,2 risk factors, OS is higher in LT group.

Conclusion: If no or mild liver cirrhosis, LR can be performed even the patient have 1 risk factor. But when the patient with moderate to severe cirrhosis, resection can be performed without any risk factor. LT have to be considered in patient with 2 risk factors even the mild cirrhotic liver. And If the patient with moderate to severe cirrhosis, even the 1 risk factors, transplantation have to be considered.

CITATION INFORMATION: Yoon K., Lee K., Hong S., Cho J-.H., Lee J-.M., Yi N-.J., Suh K. Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yoon K, Lee K, Hong S, Cho J-H, Lee J-M, Yi N-J, Suh K. Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis [abstract]. https://atcmeetingabstracts.com/abstract/which-way-to-go-liver-resection-or-liver-transplantation-for-hepatocellular-carcinoma-in-child-a-liver-cirrhosis-2/. Accessed January 19, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.